Compare ARK Genomic Revolution ETF (ARKG) vs Enphase Energy Inc (ENPH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Enphase Energy Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Enphase Energy Inc trades at $44.27 (market cap $5.91B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | ENPH | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $72.33 |
52-Week Low | $23.09 | $26.12 |
Market Cap | — | $5.91B |
Enterprise Value | — | $5.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ENPH trades at $44.83, down 0.13% with a bearish technical signal. Recent earnings beats (Q1 2026 EPS $0.47 vs. $0.43 expected) contrast with declining revenue trends (2025: $1.47B vs. 2023 peak $2.3B). Analyst consensus is mixed (40% Buy, 51% Hold) with a $42.79 price target below current levels. News highlights product launches like IQ9N microinverters and Open Compute Project membership, aiming to leverage AI data center demand.
Outlook remains cautious due to revenue volatility and high valuation (P/E 44.39). Opportunities exist in new product adoption and regulatory tailwinds (FCC inverter import ban proposal, Reuters June 2026), but risks include solar sector competition and execution challenges. Institutional sentiment is neutral with modest net cash flow of $10.20M in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →
